Sartorius names new president for North America

Maurice Phelan has succeeded Mary Lavin as president of Sartorius North America.

Maurice Phelan, president of Sartorius North America.
Maurice Phelan, president of Sartorius North America.

Phelan has spent many years in the industry and recently rejoined Sartorius from Repligen, where he was vice president of Fluid Management. Before that, he served as Head of Operations of the Sartorius site in Marlborough, Massachusetts. Previously, he held leadership roles at GE Healthcare and Merck Millipore. Phelan holds degrees in chemistry and experimental physics from the National University of Ireland.

Headquartered in Bohemia, New York, Sartorius North America currently employs more than 3,000 people across 17 sites in the US and Canada.

“Many innovations in the biopharmaceutical industry come from North America, which is also home to many of our customers. Therefore, the region has been and will continue to be one of Sartorius’ most important markets,” said René Fáber, member of the executive board of Sartorius. “With his broad industry experience, Maurice will help us to further expand activities of our lab and bioprocessing divisions, facilitating cross-functional divisional alignment and business development in the region.”

Sartorius has been investing in building new capacities in North America over recent years. In Yauco, Puerto Rico, the company has extended its cleanroom capacity for manufacturing products such as filter membranes and single-use bags, while construction is underway in Ann Arbor, Michigan, for a new 130,000 sq ft state-of-the-art plant set to open by the end of 2023, creating a Center of Excellence for BioAnalytics in North America. In 2021, Sartorius opened a 40,000 sq ft Customer Interaction Center in Marlborough, Massachusetts, for optimizing factory acceptance testing and commissioning of new bioprocess equipment.